Medicute Therapeutics LLC

Raising $5.6M First to File, First to Market generic drug in a rare disease metabolic disease

Facebook Twitter LinkedIn

Developing first generic drug for a group of rare disease. This will lower the cost of the treatment and improve accessibility for the pediatric patients needing this vital therapy. 

Ready to Ask For Funding for your company?

Post a Funding Request

Medicute Therapeutics LLC is no longer seeking funding.

Key Facts

Industry
{{model.industry | ffIndustry}}
Location
{{model.city_state}}
Year Founded
{{model.year_founded}}
Monthly Income
{{model.monthly_income | ffIncome}}
Website
{{model.homepage_url}}